The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACIC.L Regulatory News (ACIC)

  • There is currently no data for ACIC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Changes to Board Composition

29 Jul 2022 14:33

RNS Number : 3035U
abrdn China Investment Company Ltd.
29 July 2022
 

abrdn China Investment Company Limited

LEI: 213800RIA1NX8DP4P938

 

29 July 2022

 

Changes to Board Composition

 

Following the recent statement made in the Company's Half Yearly Report, the Board is pleased to announce the following changes to its composition. All of the changes will take effect from 1 August 2022.

 

Appointment of Director

The Board is pleased to announce the appointment of Mark Bridgeman as an independent non-executive director of the Company. Until 2009, Mark had a 19 year executive career in fund management at Schroders plc, as an analyst, fund manager and latterly Global Head of Research. Previous roles at Schroders included Head of Pan European Research, Head of Global Sector Research and an Emerging Markets Fund Manager. He is currently a non-executive director of Utilico Emerging Markets Trust plc.

 

In the past five years, Mark has been a director of The Law Debenture Corporation PLC, BlackRock Emerging Europe PLC and JPMorgan Brazil Investment Trust PLC. He was Chairman of the Audit Committee for two of these companies, The Law Debenture Corporation PLC and JPMorgan Brazil Investment Trust PLC.

 

Upon his appointment to the Board, Mark will take on the role of Chairman of the Audit Committee.

 

Mark will stand for election at the Annual General Meeting to be held in 2023.

 

There are no other disclosures required under Section 9.6.13 of the Listing Rules in relation to this appointment.

 

Chairman and Senior Independent Director

As previously indicated, Mark Hadsley-Chaplain will retire as Chairman and a Director. He will be succeeded as Chairman by Helen Green, who is currently Senior Independent Director and Chair of the Audit Committee.

 

Sarah MacAulay will be appointed as Senior Independent Director.

 

Commentary

The Board would like to thank Mark Hadsley-Chaplain for his significant contribution to the Company as a Director since 2012 and Chairman since 2017, and in particular in relation to the scheme of arrangement and change of mandate of the Company in 2021. The Board welcomes Mark Bridgeman as a Director and looks forward to working with him and benefiting from his extensive experience in the fund management sector.

 

Enquiries:

Aberdeen Standard Fund Managers Limited (Alternative Investment Fund Manager to the Company)

 

Evan Bruce-Gardyne

Tel: +44 (0)7720 073216

 

Luke Mason

Tel +44 (0)207 463 5971

Sanne Fund Services (UK) Limited (UK Administration Agent)

Brian Smith

Tel: +44 (0)20 3327 9720

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGZNFLMGZZM
Date   Source Headline
11th Mar 202411:30 amRNSResult of First General Meeting
8th Mar 20242:44 pmRNSResult of Elections
7th Mar 202412:36 pmRNSNet Asset Value(s)
7th Mar 20247:30 amRNSSuspension-Abrdn China Investment Company Limited
6th Mar 20245:25 pmRNSMonth End Net Asset Value(s)
6th Mar 202411:47 amRNSNet Asset Value(s)
5th Mar 202412:41 pmRNSNet Asset Value(s)
4th Mar 20242:18 pmRNSGearing disclosure
4th Mar 202412:13 pmRNSNet Asset Value(s)
1st Mar 202410:00 amRNSDoc re. Annual Report
29th Feb 202412:55 pmRNSNet Asset Value(s)
28th Feb 202411:33 amRNSNet Asset Value(s)
27th Feb 202412:46 pmRNSNet Asset Value(s)
26th Feb 20245:36 pmRNSGearing Disclosures
26th Feb 202412:42 pmRNSNet Asset Value(s)
23rd Feb 202412:21 pmRNSNet Asset Value(s)
22nd Feb 202412:44 pmRNSNet Asset Value(s)
21st Feb 202412:48 pmRNSNet Asset Value(s)
20th Feb 202412:36 pmRNSNet Asset Value(s)
19th Feb 202412:50 pmRNSGearing disclosure
19th Feb 202411:56 amRNSNet Asset Value(s)
16th Feb 20244:05 pmRNSAnnual Financial Report
16th Feb 20244:00 pmRNSPublication of Circular
16th Feb 202412:35 pmRNSNet Asset Value(s)
15th Feb 202411:06 amRNSNet Asset Value(s)
14th Feb 202412:36 pmRNSNet Asset Value(s)
14th Feb 202410:41 amRNSPortfolio Disclosures
13th Feb 202412:22 pmRNSNet Asset Value(s)
9th Feb 202412:34 pmRNSNet Asset Value(s)
8th Feb 202411:53 amRNSNet Asset Value(s)
7th Feb 20241:12 pmRNSNet Asset Value(s)
7th Feb 202411:18 amRNSMonth End Net Asset Value(s)
6th Feb 202412:12 pmRNSNet Asset Value(s)
5th Feb 20244:01 pmRNSGearing disclosure
5th Feb 202412:14 pmRNSNet Asset Value(s)
2nd Feb 20244:00 pmRNSQuarterly disclosure
2nd Feb 202412:36 pmRNSNet Asset Value(s)
31st Jan 202412:39 pmRNSNet Asset Value(s)
30th Jan 202411:52 amRNSNet Asset Value(s)
29th Jan 20242:07 pmRNSGearing disclosure
29th Jan 202411:53 amRNSNet Asset Value(s)
26th Jan 202412:17 pmRNSNet Asset Value(s)
25th Jan 202412:24 pmRNSNet Asset Value(s)
24th Jan 202412:36 pmRNSNet Asset Value(s)
23rd Jan 202412:15 pmRNSNet Asset Value(s)
22nd Jan 20242:02 pmRNSGearing disclosure
22nd Jan 202411:51 amRNSNet Asset Value(s)
19th Jan 202411:22 amRNSNet Asset Value(s)
18th Jan 202410:58 amRNSNet Asset Value(s)
17th Jan 202411:59 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.